Vira Regen Competitors and Similar CompaniesClear all
Vira Regen's competitors and similar companies include CureVac, Deciphera Pharmaceuticals and AnaptysBio.
 Vira Regen Vira Regen is a regenerative biotech company that specializes in gene-specific electroceuticals. |  Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates. | ||
Founding Date | Founding Date 2023 | Founding Date 2000 | Founding Date 2003 | Founding Date 2005 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Salt Lake City, US HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Waltham, US HQ Lawrence, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 3 | Employees 82517% decrease | Employees 35037% increase | Employees 898% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 648.3 m | Valuation ($) 2.2 b | Valuation ($) 930.2 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) $234.6m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods $3.7m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit $159.6m (FY, 2023) | Gross profit N/A |
Net income | Net income N/A | Net income €162.2m (FY, 2024) | Net income ($194.9m) (FY, 2023) | Net income N/A |
Operating ⚠ | ||||
Patent Applications | Patent Applications N/A | Patent Applications 500 (Mar, 2020) | Patent Applications 49 (Aug, 2017) | Patent Applications N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.1b | Total funding raised $ 714m | Total funding raised $ 83.9m |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyDeciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View companyAnaptysBio
HQ
San Diego, US
Employees
89↓ 8% decrease
AnaptysBio is a biotechnology company developing immunology therapeutic product candidates.
View company